Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$98.32 USD

98.32
21,578,090

-0.84 (-0.85%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $98.81 +0.49 (0.50%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 43% (106 out of 247)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Zacks Equity Research

Pharmacy Services Aid CVS Health, Aetna Deal an Upside Too

by Zacks Equity Research

CVS Health (CVS) is likely to earn $750 million from near-term synergies after the completion of Aetna acquisition deal.

    Zacks Equity Research

    Top Analyst Reports for Broadcom, Canadian National & CVS Health

    by Zacks Equity Research

    Today's Research Daily features new research reports on 16 major stocks, including Broadcom (AVGO), Canadian National (CNI) and CVS Health (CVS).

      Zacks Equity Research

      Walgreens (WBA) May Buy Remaining Stake in AmerisourceBergen

      by Zacks Equity Research

      Walgreens' (WBA) rumored buyout claim over the remaining stake in AmerisourceBergen comes close on the heels of its rival CVS Health's hefty $69-billion worth acquisition of health insurer, Aetna.

        Zacks Equity Research

        CVS Health (CVS) Beats On Q4 Earnings & Revenues Estimates

        by Zacks Equity Research

        CVS Health (CVS) rides high on strength in Pharmacy Services segment in Q4.

          Zacks Equity Research

          Health Insurance Stock Outlook - January 2018

          by Zacks Equity Research

          Rapid evolution is being witnessed in the health insurance industry as the players are taking concerted efforts to transform themselves into comprehensive health care providers from their earlier role of traditional payers.

            Zacks Equity Research

            Fred's (FRED) Sluggish Store Sales Keep Investors at Bay

            by Zacks Equity Research

            Fred's (FRED) continues to witness dismal comps and store closures. Also, cancelled dividend and merger deal make this retailer a less-favored pick.

              Zacks Equity Research

              5 Reasons Why McKesson Deserves a Place in Your Portfolio

              by Zacks Equity Research

              McKesson (MCK) continues to pursue deals, divestitures and acquisitions to drive growth. The company's impressive performance in 2017 accounts for its potential to sustain the momentum.

                Zacks Equity Research

                Company News For January 5, 2018

                by Zacks Equity Research

                Companies In The News are:

                  Zacks Equity Research

                  CVS Health's (CVS) Outlook for 2018 Cheered by Investors

                  by Zacks Equity Research

                  CVS Health (CVS) to witness increased cash flow of around $1.2 billion in 2018, courtesy the latest US Tax legislation.

                    Zacks Equity Research

                    Fred's Tanks 79% in a Year: Any Chances of Revival Ahead?

                    by Zacks Equity Research

                    Fred's (FRED) has been struggling with its dismal comps performance stemming from receding traffic and store closures. Also, management cancelled its quarterly dividend recently.